Confronto
Epitalon vs. Lanreotid
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
307297-39-8
108736-35-2
Peso molecolare
390.35 g/mol
1096.34 g/mol
Emivita
0.3 h
nessun dato
Sequenza
Ala-Glu-Asp-Glynessun dato
Meccanismo d'azione
Epitalon
Postulated mechanisms include modulation of gene expression in pinealocytes, telomerase activation (observed in cell culture studies) and influence on melatonin synthesis. A defined primary receptor is not established; the mechanistic basis rests on in-vitro and animal data from the Khavinson group.
Lanreotid
Lanreotide activates somatostatin receptors (chiefly SSTR2, additionally SSTR5), thereby suppressing the release of growth hormone, IGF-1 and various gastrointestinal and neuroendocrine hormones. It is metabolically far more stable than natural somatostatin.
Base di evidenze
Evidenza più alta
Studio sull'uomo
RCT sull'uomo
Studi
4
1
di cui sull'uomo
1
1
Effetti registrati
4
2
Contraddizioni aperte
1
1
Eventi avversi documentati
1
2
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Epitalon and Lanreotid?
- Epitalon is classified as "Ricerca (altro)", while Lanreotid is classified as "Ricerca (altro)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Lanreotid: Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It binds preferentially to the somatostatin receptors SSTR2 and SSTR5 and is approved for treating acromegaly and certain neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Epitalon or Lanreotid?
- The highest available evidence level is "Studio sull'uomo" for Epitalon and "RCT sull'uomo" for Lanreotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Epitalon and Lanreotid in Germany and the United States?
- Germania: Epitalon — Non approvato, Lanreotid — Su prescrizione. Stati Uniti: Epitalon — Non approvato, Lanreotid — Su prescrizione. These are factual summaries with source and review date on the individual pages.